Description
XA-3(RT)/Cagrilintide research blend — 12.5 mg / 2.5 mg
This Xtreme Aminos catalog item is a combined research blend with listed component quantities of 12.5 mg XA-3(RT) and 2.5 mg Cagrilintide per vial.
Listed component quantities
| Component | Listed amount per vial |
|---|---|
| XA-3(RT) | 12.5 mg |
| Cagrilintide | 2.5 mg |
| Combined listed quantity | 15 mg |
The 12.5 mg / 2.5 mg notation identifies two component amounts; it does not mean 12.5 mg of each component. The 15 mg sum describes the listed formulation, not an independently measured content result or purity percentage.
Distinguish the blend from individual products
This is a separate item from individual XA-3(RT) and Cagrilintide 10 mg. Compare the complete formulation rather than relying on a shared ingredient name. Keep both component amounts in purchasing and inventory records.
Ask about blend-specific documentation
Email info@xtremeaminos.com with the full blend name, 12.5 mg / 2.5 mg quantities, and lot identifier if available. Ask which specifications, COA, and safety documents are available for the combined material. An ingredient report alone does not establish the composition or analytical results of the supplied blend. Review the components, lot, methods, and results identified in the actual documents.
Receiving records
Match the label to the ordered formulation, inspect the container, and retain the lot number and receiving date. Follow our receiving checklist and documentation request guide.
For lawful nonclinical laboratory research and education by qualified researchers only. Not for human or veterinary administration, personal consumption, food use, or clinical, therapeutic, or diagnostic use. Follow the label, available safety documentation, and your institution’s procedures for handling, storage, and disposal.
Reviews
There are no reviews yet.